Medivie Financial Statements From 2010 to 2024
| MDVI Stock | ILA 35.50 2.00 5.97% |
Check Medivie Therapeutic financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medivie Therapeutic's main balance sheet or income statement drivers, such as , as well as many indicators such as . Medivie financial statements analysis is a perfect complement when working with Medivie Therapeutic Valuation or Volatility modules.
Medivie |
Medivie Therapeutic Company Return On Asset Analysis
Medivie Therapeutic's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Medivie Therapeutic Return On Asset | -1.09 |
Most of Medivie Therapeutic's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medivie Therapeutic is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Medivie Therapeutic has a Return On Asset of -1.0886. This is 87.56% lower than that of the Healthcare sector and 96.25% lower than that of the Medical Instruments & Supplies industry. The return on asset for all Israel stocks is notably higher than that of the company.
Medivie Therapeutic Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medivie Therapeutic's current stock value. Our valuation model uses many indicators to compare Medivie Therapeutic value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medivie Therapeutic competition to find correlations between indicators driving Medivie Therapeutic's intrinsic value. More Info.Medivie Therapeutic is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Medivie Therapeutic by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Medivie Therapeutic's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Medivie Therapeutic Financial Statements
Medivie Therapeutic stakeholders use historical fundamental indicators, such as Medivie Therapeutic's revenue or net income, to determine how well the company is positioned to perform in the future. Although Medivie Therapeutic investors may analyze each financial statement separately, they are all interrelated. For example, changes in Medivie Therapeutic's assets and liabilities are reflected in the revenues and expenses on Medivie Therapeutic's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Medivie Therapeutic. Please read more on our technical analysis and fundamental analysis pages.
Medivie Therapeutic Limited develops and markets dental devices. Medivie Therapeutic Limited was founded in 2012 and is based in Hemel Hempstead, the United Kingdom. MEDIVIE THERP is traded on Tel Aviv Stock Exchange in Israel.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Medivie Stock
Medivie Therapeutic financial ratios help investors to determine whether Medivie Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medivie with respect to the benefits of owning Medivie Therapeutic security.